pharma · SH2B1 Deficiency Obesity · Prader-Willi Syndrome · SLNO
SOLENO THERAPEUTICS
SOLENO THERAPEUTICS INC
SOLENO THERAPEUTICS patent portfolio — 0 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.
Redwood City, USA HQ
199 Employees
Public company Type
SLNO · NYSE Ticker
Company details
- Status
- Public
- HQ
- Redwood City, USA
- Employees
- 199
- Programs
- 2
- Drugs
- 4
- Patents
- 0
SOLENO THERAPEUTICS patents
0 pharmaceutical patents indexed for SOLENO THERAPEUTICS. 0 expire within 24 months.
SOLENO THERAPEUTICS has 0 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 0 expire within 24 months — use filters for patent-cliff planning.
No patents matched
Frequently asked questions
How many patents does SOLENO THERAPEUTICS have?
0 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).
When do SOLENO THERAPEUTICS patents expire?
0 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.